搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Nitrosomonas eutropha Heme A synthase (ctaA), partial CSB-YP602693NAAD
CSB-EP602693NAAD
CSB-BP602693NAAD
CSB-MP602693NAAD
CSB-EP602693NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 50S ribosomal protein L15 (rplO) CSB-YP602694NAAD
CSB-EP602694NAAD
CSB-BP602694NAAD
CSB-MP602694NAAD
CSB-EP602694NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 50S ribosomal protein L24 (rplX) CSB-YP602695NAAD
CSB-EP602695NAAD
CSB-BP602695NAAD
CSB-MP602695NAAD
CSB-EP602695NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 50S ribosomal protein L4 (rplD) CSB-YP602696NAAD
CSB-EP602696NAAD
CSB-BP602696NAAD
CSB-MP602696NAAD
CSB-EP602696NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Elongation factor Tu 1 (tuf1) CSB-YP602697NAAD
CSB-EP602697NAAD
CSB-BP602697NAAD
CSB-MP602697NAAD
CSB-EP602697NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Diaminopimelate epimerase (dapF) CSB-YP602698NAAD
CSB-EP602698NAAD
CSB-BP602698NAAD
CSB-MP602698NAAD
CSB-EP602698NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Aspartate carbamoyltransferase (pyrB) CSB-YP602699NAAD
CSB-EP602699NAAD
CSB-BP602699NAAD
CSB-MP602699NAAD
CSB-EP602699NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Ribosome maturation factor RimM (rimM) CSB-YP602700NAAD
CSB-EP602700NAAD
CSB-BP602700NAAD
CSB-MP602700NAAD
CSB-EP602700NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Cytidylate kinase (cmk) CSB-YP602701NAAD
CSB-EP602701NAAD
CSB-BP602701NAAD
CSB-MP602701NAAD
CSB-EP602701NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 3-dehydroquinate synthase (aroB) CSB-YP602702NAAD
CSB-EP602702NAAD
CSB-BP602702NAAD
CSB-MP602702NAAD
CSB-EP602702NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP602703NAAD
CSB-EP602703NAAD
CSB-BP602703NAAD
CSB-MP602703NAAD
CSB-EP602703NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha ATP synthase gamma chain (atpG) CSB-YP602704NAAD
CSB-EP602704NAAD
CSB-BP602704NAAD
CSB-MP602704NAAD
CSB-EP602704NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP602705NAAD
CSB-EP602705NAAD
CSB-BP602705NAAD
CSB-MP602705NAAD
CSB-EP602705NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP602706NAAD
CSB-EP602706NAAD
CSB-BP602706NAAD
CSB-MP602706NAAD
CSB-EP602706NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maricaulis maris Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP602707MAAJ
CSB-EP602707MAAJ
CSB-BP602707MAAJ
CSB-MP602707MAAJ
CSB-EP602707MAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maricaulis maris DNA mismatch repair protein MutS (mutS), partial CSB-YP602708MAAJ
CSB-EP602708MAAJ
CSB-BP602708MAAJ
CSB-MP602708MAAJ
CSB-EP602708MAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maricaulis maris Shikimate dehydrogenase (aroE) CSB-YP602709MAAJ
CSB-EP602709MAAJ
CSB-BP602709MAAJ
CSB-MP602709MAAJ
CSB-EP602709MAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maricaulis maris Cytochrome c biogenesis ATP-binding export protein CcmA (ccmA) CSB-YP602710MAAJ
CSB-EP602710MAAJ
CSB-BP602710MAAJ
CSB-MP602710MAAJ
CSB-EP602710MAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maricaulis maris ATP synthase subunit alpha (atpA), partial CSB-YP602711MAAJ
CSB-EP602711MAAJ
CSB-BP602711MAAJ
CSB-MP602711MAAJ
CSB-EP602711MAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maricaulis maris 30S ribosomal protein S21 (rpsU) CSB-YP602712MAAJ
CSB-EP602712MAAJ
CSB-BP602712MAAJ
CSB-MP602712MAAJ
CSB-EP602712MAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>